Kymera Therapeutics, Inc.
(NASDAQ: KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.

65.000

-1.230 (-1.86%)
Range 64.930 - 67.000   (3.19%)
Open 66.360
Previous Close 66.230
Bid Price 29.430
Bid Volume 11
Ask Price 29.470
Ask Volume 8
Volume 44,696
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 00:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis